Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer

Authors:
  • KIKeisuke Ieta
    Keisuke Ieta
  • FTFumiaki Tanaka
    Fumiaki Tanaka
  • TYTakehiko Yokobori
    Takehiko Yokobori
  • YKYoshiaki Kita
    Yoshiaki Kita
  • NHNaotsugu Haraguchi
    Naotsugu Haraguchi
  • KMKoshi Mimori
    Koshi Mimori
  • HKHiroyuki Kato
    Hiroyuki Kato
  • TATakayuki Asao
    Takayuki Asao
  • HIHiroshi Inoue
    Hiroshi Inoue
  • HKHiroyuki Kuwano
    Hiroyuki Kuwano
  • MMMasaki Mori
    Masaki Mori

Abstract
Laser microdissection (LMD) and microarray were used to identify genes associated with colorectal cancer. Stanniocalcin 2 (STC2) expression and clinicopathological significance in 139 clinical colorectal cancer samples were specifically investigated using real‐time quantitative reverse transcription‐polymerase chain reaction. A number of genes upregulated in colorectal cancer cells compared to normal colorectal epithelial cells were identified including STC2. STC2 gene expression in cancer tissue was higher than in corresponding normal colorectal epithelial tissue in 124 of 139 cases (89.2%, p < 0.01). Tumors with high STC2 expression showed higher frequencies of lymph node metastasis, lymphatic invasion, tumor depth, tumor size and AJCC Stage classification (p < 0.01). Patients with high STC2 expression also showed significantly worse overall survival rates than those with low STC2 expression (p < 0.01). Furthermore, STC2 gene appeared to be associated with colorectal cancer progression and may be a useful prognostic indicator for colorectal cancer. © 2009 UICC

This publication has 33 references indexed in Scilit: